AB+ GLP Power Stack™

Retatrutide 10 mg & Cagrilintide 5 mg

Product Description The AB+ GLP Power Stack™ combines Retatrutide (10 mg), a triple receptor agonist (GLP-1/GIP/glucagon), with Cagrilintide (5 mg), a long-acting amylin analog. Supplied as two separate ≥98% pure lyophilized powders (HPLC/MS verified) in one convenient research kit, this stack is designed for laboratory studies on advanced metabolic regulation, appetite control, energy expenditure, and body composition.

Key Research Mechanism Retatrutide activates GLP-1, GIP, and glucagon receptors to promote insulin secretion, suppress appetite, slow gastric emptying, and increase energy expenditure. Cagrilintide acts as a dual amylin/calcitonin receptor agonist, enhancing satiety signaling in the brain. Together, they target complementary pathways for synergistic effects on food intake, fat metabolism, and glucose homeostasis in research models.

Primary Research Areas

• Advanced weight management and obesity models (enhanced body weight and adiposity reduction)
• Multi-receptor metabolic regulation and energy expenditure
• Appetite suppression and satiety pathway studies
• Glucose control, insulin sensitivity, and overall metabolic health research

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.